🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

MASCoD - Multidimensional Assessment of Subjective Cognitive Decline

RecruitingNAAges 55 Years - anyAllIstituti Clinici Scientifici Maugeri SpA
NCT05815329 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Subjective cognitive decline-SCD is a subclinical cognitive impairment subjectively experienced without being detectable from a diagnostic and neuropsychological perspective. It can negatively impact on patient's frailty and quality of life and it may be prodromal to severe cognitive impairment. Currently, only a few screening tools focusing mainly on memory complaints exist. The aim of this study is to analyze if a new screening tool called MASCoD (Multidimensional Assessment of Subjective Cognitive Decline) can detect and monitor the SCD, predicting the risk of developing severe cognitive decline over time. Specifically, the investigators have the following aims: primary objectives: 1. To assess the construct validity and tune the clinical cutoffs of the new instrument through the correlation of MASCoD scores with neuropsychological evaluation and brain 18F-FDG-PET. 2. To assess th

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * reported subjective cognitive decline without any other cognitive or neurological issue, * Italian education, * adult (\> 55 years old), * understanding of research aims, * signed informed consent, * participation on a voluntary and non-payied bases. Exclusion Criteria: * serious clinical conditions (e.g. severe cardiac and respiratory problems, neoplasia) * prior diagnosis of psychiatric disorders according to DSM-5, * prior diagnosis of cognitive decline, * relevant visuo-perceptive or hearing deficits, * illiteracy or relapse in illiteracy, * refusal to partake in the research.
💊

What it tests

  • cognitive training
📍

Where

1 site
ICS Maugeri Montescano Institute
Montescano, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy